Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin & Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin & Linagliptin.
All content for EXCEL 2.2 Podcast is the property of Lupin, India and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin & Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin & Linagliptin.
Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin | Dr. Debmalya Sanyal & Dr. Mahuya Sikdar
EXCEL 2.2 Podcast
14 minutes 8 seconds
3 years ago
Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin | Dr. Debmalya Sanyal & Dr. Mahuya Sikdar
Listen to the Experts Discuss the Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin .
EXCEL 2.2 Podcast
Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin & Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin & Linagliptin.
